<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?subarticle d1e1832?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
    <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
    <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
    <journal-title-group>
      <journal-title>GigaByte</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2709-4715</issn>
    <publisher>
      <publisher-name>GigaScience Press</publisher-name>
      <publisher-loc>Sha Tin, New Territories, Hong Kong SAR</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10027063</article-id>
    <article-id pub-id-type="publisher-manuscript">TRR-202209-01</article-id>
    <article-id pub-id-type="publisher-id">72</article-id>
    <article-id pub-id-type="doi">10.46471/gigabyte.72</article-id>
    <article-id pub-id-type="arxiv" specific-use="preprint">https://doi.org/10.1101/2022.09.12.507681</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Technical Release</subject>
      </subj-group>
      <subj-group subj-group-type="classification">
        <subject>Software and Workflows</subject>
        <subject>Cell Biology</subject>
        <subject>Systems Biology</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PhysiPKPD: A pharmacokinetics and pharmacodynamics module for PhysiCell</article-title>
      <alt-title alt-title-type="left-running-head">D. Bergman <italic toggle="yes">et¬†al.</italic>
</alt-title>
      <alt-title alt-title-type="right-running-head">PhysiPKPD: A pharmacokinetics and pharmacodynamics module for PhysiCell</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2166-6616</contrib-id>
        <name>
          <surname>Bergman</surname>
          <given-names>Daniel</given-names>
        </name>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization" degree-contribution="Equal">Conceptualization</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology" degree-contribution="lead">Methodology</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/software/" vocab-term="Software" degree-contribution="lead">Software</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation" degree-contribution="lead">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization" degree-contribution="lead">Visualization</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing - original draft" degree-contribution="lead">Writing - original draft</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing" degree-contribution="Equal">Writing - review editing</role>
        <xref rid="aff000a" ref-type="aff">
          <sup>1</sup>
        </xref>
        <xref rid="cor1" ref-type="corresp">
          <sup>*</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7425-9467</contrib-id>
        <name>
          <surname>Marazzi</surname>
          <given-names>Lauren</given-names>
        </name>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization" degree-contribution="Equal">Conceptualization</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/software/" vocab-term="Software" degree-contribution="Equal">Software</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation" degree-contribution="Equal">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing" degree-contribution="Equal">Writing - review editing</role>
        <xref rid="aff000b" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="fn0001" ref-type="author-notes">
          <sup>‚Ä†</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9761-1235</contrib-id>
        <name>
          <surname>Chowkwale</surname>
          <given-names>Mukti</given-names>
        </name>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization" degree-contribution="Equal">Conceptualization</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/software/" vocab-term="Software" degree-contribution="Equal">Software</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation" degree-contribution="Equal">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing" degree-contribution="Equal">Writing - review editing</role>
        <xref rid="aff000c" ref-type="aff">
          <sup>3</sup>
        </xref>
        <xref rid="fn0001" ref-type="author-notes">
          <sup>‚Ä†</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8879-8357</contrib-id>
        <name>
          <surname>Maheshvare M</surname>
          <given-names>Deepa</given-names>
        </name>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/software/" vocab-term="Software" degree-contribution="Equal">Software</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation" degree-contribution="Equal">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing" degree-contribution="Equal">Writing - review editing</role>
        <xref rid="aff000d" ref-type="aff">
          <sup>4</sup>
        </xref>
        <xref rid="fn0001" ref-type="author-notes">
          <sup>‚Ä†</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bidanta</surname>
          <given-names>Supriya</given-names>
        </name>
        <xref rid="aff000e" ref-type="aff">
          <sup>5</sup>
        </xref>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/software/" vocab-term="Software">Software</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing">Writing - review editing</role>
        <xref rid="fn0001" ref-type="author-notes">
          <sup>‚Ä†</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1630-0716</contrib-id>
        <name>
          <surname>Mapder</surname>
          <given-names>Tarunendu</given-names>
        </name>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization" degree-contribution="Equal">Conceptualization</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation" degree-contribution="Equal">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing" degree-contribution="Equal">Writing - review editing</role>
        <xref rid="aff000f" ref-type="aff">
          <sup>6</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Jialun</given-names>
        </name>
        <xref rid="aff000g" ref-type="aff">
          <sup>7</sup>
        </xref>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/validation/" vocab-term="Validation">Validation</role>
        <role vocab="Casrai/NISO CRediT" vocab-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing - review editing">Writing - review editing</role>
      </contrib>
      <aff id="aff000a"><label><sup>1</sup></label><addr-line content-type="department">Department of Mathematics</addr-line>, <institution>University of Michigan</institution>, <addr-line content-type="city">Ann Arbor</addr-line>, <addr-line>MI 48109</addr-line>, <country>USA</country></aff>
      <aff id="aff000b"><label><sup>2</sup></label><addr-line content-type="department">Center for Quantitative Medicine</addr-line>, <institution>University of Connecticut School of Medicine</institution>, <addr-line content-type="city">Farmington</addr-line>, <addr-line>CT 06030</addr-line>, <country>USA</country></aff>
      <aff id="aff000c"><label><sup>3</sup></label><addr-line content-type="department">Department of Biomedical Engineering</addr-line>, <institution>University of Virginia</institution>, <addr-line content-type="city">Charlottesville</addr-line>, <addr-line>VA 22908</addr-line>, <country>USA</country></aff>
      <aff id="aff000d"><label><sup>4</sup></label><addr-line content-type="department">Department of Computational and Data Sciences</addr-line>, <institution>Indian Institute of Science</institution>, <addr-line content-type="city">Bengaluru 560012</addr-line>, <country>India</country></aff>
      <aff id="aff000e"><label><sup>5</sup></label><institution>Indiana University</institution>, <addr-line content-type="city">Bloomington</addr-line>, <addr-line>IN 47405</addr-line>, <country>USA</country></aff>
      <aff id="aff000f"><label><sup>6</sup></label><addr-line content-type="department">Quantitative Systems Pharmacology</addr-line>, <addr-line content-type="city">Bristol-Myers Squibb</addr-line>, <addr-line content-type="city">Princeton Lawrenceville</addr-line>, <addr-line>NJ</addr-line>, <country>USA</country></aff>
      <aff id="aff000g"><label><sup>7</sup></label><institution>McGill University</institution>, <addr-line content-type="city">Montr√©al</addr-line>, <addr-line>QC H3A 0G4</addr-line>, <country>Canada</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label><sup>*</sup></label> Corresponding author. E-mail: <email xlink:href="bergmand@umich.edu">bergmand@umich.edu</email>
</corresp>
      <fn id="fn0001">
        <label>
          <sup>‚Ä†</sup>
        </label>
        <p>Contributed equally.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>2022</volume>
    <elocation-id>gigabyte72</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>10</day>
        <month>11</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>¬©¬†The Author(s) 2022.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" specific-use="url" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Pharmacokinetics and pharmacodynamics (PKPD) are key considerations in any study of molecular therapies. It is thus imperative to factor their effects into any <italic toggle="yes">in silico</italic> model of biological tissue involving such therapies. Furthermore, creating a standardized and flexible framework will benefit the community by increasing access to such modules and enhancing their communicability. PhysiCell is an open-source physics-based cell simulator, i.e., a platform for modeling biological tissue, that is quickly being adopted and utilized by the mathematical biology community. We present here PhysiPKPD, an open-source PhysiCell-based package that allows users to include PKPD in PhysiCell models.</p>
      <sec specific-use="heading-level-1" id="s0001">
        <title>Availability &amp; Implementation</title>
        <p>The source code for PhysiPKPD is located here: <ext-link xlink:href="https://github.com/drbergman/PhysiPKPD" ext-link-type="uri" specific-use="url">https://github.com/drbergman/PhysiPKPD</ext-link>. </p>
      </sec>
    </abstract>
  </article-meta>
</front>
<body>
  <sec id="s0002">
    <title>Statement of need</title>
    <p>Agent-based modeling has become a common tool for research in systems biology. However, it is still a relatively new tool and the community remains in need of standardized models that promote accessibility and extensibility. The PhysiCell platform is one such effort to achieve this¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref2" ref-type="bibr">2</xref>]</styled-content>. It is open-source, actively maintained, and has taken significant steps towards being widely adopted, as evidenced by the release of PhysiBoSS <styled-content style-type="bibr-wrapper">[<xref rid="ref3" ref-type="bibr">3</xref>]</styled-content>, an independently-developed integration of PhysiCell with intracellular signaling using Boolean modeling. New add-ons to PhysiCell will further broaden its appeal and facilitate the use of standards that will achieve the aforementioned community goals of accessibility and extensibility.</p>
    <p>Many agent-based models (ABMs) have been developed to study diseases, including cancer¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref4" ref-type="bibr">4</xref>‚Äì<xref rid="ref9" ref-type="bibr">9</xref>]</styled-content>, COVID-19¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref10" ref-type="bibr">10</xref>]</styled-content>, tuberculosis¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12</xref>]</styled-content>, and more, with a core purpose being to determine the best means to treat a patient with the given disease. This involves modeling therapeutics alongside the cells in a given microenvironment. The processes that determine the effect of a given drug are commonly broken down into pharmacokinetics, or PK, and pharmacodynamics, or PD. Together, they are often called PKPD. Pharmacokinetics describes how a drug is transported throughout the body to get to the cells it acts on, i.e., the drug exposure. Pharmacodynamics describes how the drug then acts on those cells, i.e., the drug response.</p>
    <p>The dynamics involved in PKPD are generalizable to many different drugs acting in different ways. This makes it an appealing target for a single module that can flexibly handle these processes on a platform such as PhysiCell. Features on both the PK side ‚Äì such as dosing schedules, loading doses, elimination, and distribution rates ‚Äì and the PD side ‚Äì such as mechanisms of action (MOA), effect, the half maximal effective concentration or EC50, and hill coefficients ‚Äì are amenable to this level of abstraction.</p>
    <p>We present here PhysiPKPD, a standardized framework to incorporate these PKPD processes in PhysiCell. We also provide several examples demonstrating PhysiPKPD and providing users with two template projects to aid in the model-building process. In this first version, we provide three options for modeling pharmacokinetics: (1) one-compartment models, (2) two-compartment models, and (3) the ability to supply a Systems Biology Markup Language (SBML)-defined model. For options (1) and (2), the equations must be linear. On the PD side, substrates cause damage to cells based on the internalized substrate. As this damage accumulates within a cell, the MOA-associated rate parameter(s) tend towards a user-defined saturation rate. While we expect most users to add both PK and PD for a given substrate, they can be added independently if desired. For substrates that do have PD, these are set for each cell type in the model.</p>
    <fig position="float" id="gigabyte-2022-72-g001">
      <label>Figure 1.</label>
      <caption>
        <p>How to implement PhysiPKPD. (A) Using the sample projects that come with PhysiPKPD. (B) Using a template project and setting PKPD parameters in the configuration file. (C) Editing the C++ code in custom modules to further refine the model, e.g.making cell chemotax along an oxygen gradient.</p>
      </caption>
      <graphic xlink:href="gigabyte-2022-72-g001" position="float"/>
    </fig>
  </sec>
  <sec id="s0003">
    <title>Implementation</title>
    <p>We provide two ways to create and run PhysiPKPD models, shown in Figure¬†<xref rid="gigabyte-2022-72-g001" ref-type="fig">1</xref>. First, the sample projects that come with PhysiPKPD demonstrate the MOAs implemented in PhysiPKPD (Figure¬†<xref rid="gigabyte-2022-72-g001" ref-type="fig">1</xref>A). Second, the user can use the template projects to jumpstart the model-building process with the full range of possible parameters and code present throughout the PhysiCell repository (Figure¬†<xref rid="gigabyte-2022-72-g001" ref-type="fig">1</xref>B). We now explain how PhysiPKPD achieves these dynamics. In what follows, <monospace>S</monospace> will stand for the name of a substrate, <monospace>C</monospace>¬†for the name of a cell type, and X for an MOA.</p>
    <sec id="s0004">
      <title>Pharmacokinetics</title>
      <p>For pharmacokinetics, the user must first specify which substrates in the model follow a PK model. This is done by adding these substrate names to the comma-separated string user parameter <monospace>PKPD_pk_substrate_names</monospace>.</p>
      <sec id="s0005">
        <title>PK models</title>
        <p>For each of these substrates, the user should specify a PK model (see Table¬†<xref rid="gigabyte-2022-72-t001" ref-type="table">¬†1</xref>). If this is not specified, PhysiPKPD will attempt to use a two-compartment model. In addition, the user should specify a Biot number, which PhysiPKPD uses to set the ratio of perivascular substrate concentration to that in the blood vessel¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref13" ref-type="bibr">13</xref>]</styled-content>. PhysiPKPD will default to a value of 1, indicating equal concentrations inside and outside the capillary walls.</p>
        <table-wrap position="float" id="gigabyte-2022-72-t001">
          <label>Table¬†1</label>
          <caption>
            <p>PK model specifications. The specification column indicates the string value to be used in the configuration file for the parameter <monospace>S_pk_model</monospace>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col span="1" align="center" width="25%"/>
              <col span="1" align="center" width="50%"/>
              <col span="1" align="center" width="25%"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center" rowspan="1" colspan="1"> Model</th>
                <th align="center" rowspan="1" colspan="1"> Description</th>
                <th align="center" rowspan="1" colspan="1">Specification</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1"> One-compartment</td>
                <td align="center" rowspan="1" colspan="1"> Circulation compartment with linear elimination</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>1C</monospace>
                </td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1"> Two-compartment</td>
                <td align="center" rowspan="1" colspan="1"> Circulation and peripheral compartments with linear clearance rates</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>2C</monospace>
                </td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1"> SBML-defined</td>
                <td align="center" rowspan="1" colspan="1">Any SBML-defined model with one species named <monospace>circulation_concentration</monospace>
</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>SBML</monospace>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>For example, add the following to User Parameters in the configuration file: <monospace>&lt;S_pk_model type="string"&gt;2C&lt;/S_pk_model&gt;</monospace>.</p>
          </table-wrap-foot>
        </table-wrap>
        <sec id="s0006">
          <title>One-compartment models</title>
          <p>The PhysiPKPD one-compartment model obeys the differential equation <disp-formula id="eqn0001"><label>(1)</label><alternatives><tex-math id="d2e541">\documentclass[10pt]{article}
                    \usepackage{wasysym}
                    \usepackage[substack]{amsmath}
                    \usepackage{amsfonts}
                    \usepackage{amssymb}
                    \usepackage{amsbsy}
                    \usepackage[mathscr]{eucal}
                    \usepackage{mathrsfs}
                    \usepackage{pmc}
                    \usepackage[Euler]{upgreek}
                    \pagestyle{empty}
                    \oddsidemargin -1.0in \begin{document}
                    \begin{eqnarray}
                    \frac{\text{d}C}{\text{d}t}=-ùúÜC \end{eqnarray}
                    \end{document}</tex-math><mml:math id="math001" overflow="scroll"><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>‚àí</mml:mo><mml:mi>ùúÜ</mml:mi><mml:mi>C</mml:mi></mml:math></alternatives></disp-formula> where <italic toggle="yes">C</italic> represents the circulation concentration of the substrate and ùúÜ is the elimination rate (see Table¬†<xref rid="gigabyte-2022-72-t002" ref-type="table">¬†2</xref>). PhysiPKPD uses the value of <italic toggle="yes">C</italic> to update the Dirichlet conditions in the PhysiCell microenvironment after multiplying by the Biot number.</p>
          <table-wrap position="float" id="gigabyte-2022-72-t002">
            <label>Table¬†2</label>
            <caption>
              <p>PK parameters for 1- and 2-compartment models.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col span="1" align="center" width="35%"/>
                <col span="1" align="center" width="45%"/>
                <col span="1" align="center" width="10%"/>
                <col span="1" align="center" width="10%"/>
              </colgroup>
              <thead valign="top">
                <tr>
                  <th align="center" rowspan="1" colspan="1"> Parameter</th>
                  <th align="center" rowspan="1" colspan="1"> Description</th>
                  <th align="center" rowspan="1" colspan="1"> Type</th>
                  <th align="center" rowspan="1" colspan="1">Units</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><monospace>S_central_elimination_rate</monospace>¬†(ùúÜ)</td>
                  <td align="center" rowspan="1" colspan="1"> Rate of elimination of the drug in systemic circulation</td>
                  <td align="center" rowspan="1" colspan="1">
                    <monospace>double</monospace>
                  </td>
                  <td align="center" rowspan="1" colspan="1"> min<sup>‚àí1</sup>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><monospace>S_central_to_periphery_volume_ratio</monospace><sup>*</sup>¬†(<italic toggle="yes">R</italic>)</td>
                  <td align="center" rowspan="1" colspan="1">Ratio of volumes of central and peripheral compartments to conserve mass of drug during distribution and redistribution</td>
                  <td align="center" rowspan="1" colspan="1">
                    <monospace>double</monospace>
                  </td>
                  <td align="center" rowspan="1" colspan="1">None</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><monospace>S_central_to_periphery_clearance_rate</monospace><sup>*</sup>¬†(<italic toggle="yes">k</italic><sub>12</sub>)</td>
                  <td align="center" rowspan="1" colspan="1"> Rate of change in concentration in central compartment due to distribution</td>
                  <td align="center" rowspan="1" colspan="1">
                    <monospace>double</monospace>
                  </td>
                  <td align="center" rowspan="1" colspan="1"> min<sup>‚àí1</sup>
</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1"><monospace>S_periphery_to_central_clearance_rate</monospace><sup>*</sup>¬†(<italic toggle="yes">k</italic><sub>21</sub>)</td>
                  <td align="center" rowspan="1" colspan="1"> Rate of change in concentration in periphery compartment due to redistribution</td>
                  <td align="center" rowspan="1" colspan="1">
                    <monospace>double</monospace>
                  </td>
                  <td align="center" rowspan="1" colspan="1"> min<sup>‚àí1</sup>
</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <p>Replace <monospace>S</monospace> with the name of the substrate. *This parameter is not necessary for 1-compartment models.</p>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="s0007">
          <title>Two-compartment models</title>
          <p>The PhysiPKPD two-compartment model obeys the differential equation <disp-formula id="eqn0002"><label>(2)</label><alternatives><tex-math id="d2e684">\documentclass[10pt]{article}
                    \usepackage{wasysym}
                    \usepackage[substack]{amsmath}
                    \usepackage{amsfonts}
                    \usepackage{amssymb}
                    \usepackage{amsbsy}
                    \usepackage[mathscr]{eucal}
                    \usepackage{mathrsfs}
                    \usepackage{pmc}
                    \usepackage[Euler]{upgreek}
                    \pagestyle{empty}
                    \oddsidemargin -1.0in \begin{document}
                    \begin{eqnarray}
                    \begin{array}{@{}l@{}}\displaystyle \frac{\text{d}C}{\text{d}t}=\frac{k_{21}}{R}P-k_{12}C-ùúÜC\\ \displaystyle \frac{\text{d}P}{\text{d}t}=k_{12}RC-k_{21}P.\end{array}
                     \end{eqnarray}
                    \end{document}</tex-math><mml:math id="math002" overflow="scroll"><mml:mtable equalrows="false" columnlines="" equalcolumns="false" class="array"><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfrac><mml:mi>P</mml:mi><mml:mo>‚àí</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mi>C</mml:mi><mml:mo>‚àí</mml:mo><mml:mi>ùúÜ</mml:mi><mml:mi>C</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mstyle displaystyle="true"/><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mi>R</mml:mi><mml:mi>C</mml:mi><mml:mo>‚àí</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>21</mml:mn></mml:mrow></mml:msub><mml:mi>P</mml:mi><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></p>
          <p>Here, <italic toggle="yes">C</italic> and ùúÜ are as above. <italic toggle="yes">P</italic> is the periphery concentration. The parameters <italic toggle="yes">k</italic>
<sub>12</sub> and <italic toggle="yes">k</italic>
<sub>21</sub> are the intercompartmental clearance rates and <italic toggle="yes">R</italic> is the ratio of the volumes of the central and peripheral compartments (see Table¬†<xref rid="gigabyte-2022-72-t002" ref-type="table">2</xref>). PhysiPKPD uses the value of <italic toggle="yes">C</italic> to update the Dirichlet conditions in the PhysiCell microenvironment after multiplying by the Biot number. The inclusion of the periphery compartment allows for biphasic elimination in the central compartment.</p>
        </sec>
        <sec id="s0008">
          <title>SBML-defined models</title>
          <p>If the above two models are inadequate for a user‚Äôs purposes, an SBML file can be used to specify a PK model. We have used Copasi (RRID:<named-content content-type="rrid">SCR_014260</named-content>)¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref14" ref-type="bibr">14</xref>]</styled-content> to build such models, but any program that outputs an SBML file will work, e.g., sbmlutils¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref15" ref-type="bibr">15</xref>]</styled-content>. PhysiPKPD will use the first state variable of the model to update the Dirichlet conditions in the PhysiCell microenvironment after multiplying by the Biot number.</p>
        </sec>
      </sec>
      <sec id="s0009">
        <title>Dosing schedules</title>
        <p>For the one- and two-compartment models, all parameters and dosing events must be specified within the configuration file (see Table¬†<xref rid="gigabyte-2022-72-t003" ref-type="table">3</xref>). For any missing parameters, PhysiPKPD will issue warnings and use default values where it can, and it will throw errors where it must. All substrates are assumed to be given intravenously so that the concentration in the central compartment has a one-time increase upon dosing, <monospace>S_central_increase_on_dose</monospace>. These doses are given at regular intervals, <monospace>S_dose_interval</monospace>, until either the simulation ends or until the maximum number of doses has been administered. The first dose can be given at a fixed time or based on the confluence in 2D in the entire rectangular microenvironment. A loading dose can also be set with a fixed number of doses. Future releases can include other methods of administration, e.g., oral, and finer-grained control, such as more sophisticated timings for doses, e.g., M-F dosing.</p>
        <p>For SBML-defined models, the user must include dosing events in the SBML file itself. In Copasi, this can be done by creating Events that increase the concentration of a compartment(s) at certain times. In the future, we hope to allow the user to specify a CSV file with the dosing times and amounts for a substrate along with an SBML-defined system of ordinary differential equations¬†(without dosing events) that PhysiPKPD then combines into a new SBML with dosing events.</p>
        <fig position="float" id="gigabyte-2022-72-g002">
          <label>Figure 2.</label>
          <caption>
            <p>Integration of the PK and PD modules with PhysiCell. PK: (1) Administration of the drug in the central compartment. (2) Elimination of the drug. (3) Distribution of the drug into a peripheral compartment. (4) Redistribution of the drug back into the central compartment. (5) Extravasation of the drug into the microenvironment. PhysiCell: Diffusion and cellular uptake of the drug in the microenvironment. PD: the drug causes damage to cells over time. Cells can catabolize the drug and repair the damage. The damage determines the effect of the drug on its MOA.</p>
          </caption>
          <graphic xlink:href="gigabyte-2022-72-g002" position="float"/>
        </fig>
        <table-wrap position="float" id="gigabyte-2022-72-t003">
          <label>Table¬†3</label>
          <caption>
            <p>Dosing parameters for 1- and 2-compartment models.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col span="1" align="center" width="32%"/>
              <col span="1" align="center" width="45%"/>
              <col span="1" align="center" width="10%"/>
              <col span="1" align="center" width="13%"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center" rowspan="1" colspan="1"> Parameter</th>
                <th align="center" rowspan="1" colspan="1"> Description</th>
                <th align="center" rowspan="1" colspan="1"> Type</th>
                <th align="center" rowspan="1" colspan="1"> Units</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_max_number_doses</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Max number of doses to administer, including loading</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>int</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> #</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_number_loading_doses</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Of the max number of doses, number of which are loading doses</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>int</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> #</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_dose_interval</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Time between consecutive doses of <monospace>S</monospace>
</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>double</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> min</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_central_increase_on_dose</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Increase to systemic circulation concentration of substrate when a new dose is given</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>double</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> a.u.</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_central_increase_on_loading_dose</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Increase to systemic circulation concentration of substrate when a new loading dose is given</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>double</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> a.u.</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_set_first_dose_time</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Whether the user will set the time of the first dose or rely on confluence to begin dosing</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>bool</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> None</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_first_dose_time</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Time of first dose (if setting)</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>double</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> min</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_confluence_condition</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1">Proportion of microenvironment filled with cells when first dose given (if not setting first dose time)</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>double</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1">Proportion</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Replace <monospace>S</monospace> with the name of the substrate. a.u. = arbitrary units.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec id="s0010">
      <title>Pharmacodynamics</title>
      <p>Analogous to identifying substrates following a PK model, the user must specify which substrates follow a PD model. This is done by adding these substrate names to the comma-separated string user parameter <monospace>PKPD_pd_substrate_names</monospace>. While we expect this list to match that of <monospace>PKPD_pk_substrate_names</monospace> in most cases, that need not be true. For example, a substrate in the model that is produced by specific cells could result in pharmacodynamic effects on other cells. The processes of diffusion, degradation, and cellular production of such a substrate would be handled by PhysiCell ¬†and BioFVM [<xref rid="ref1" ref-type="bibr">1</xref>Ôªø].</p>
      <sec id="s0011">
        <title>Damage accumulation</title>
        <p>For each cell type affected by a particular substrate, a damage-accumulation model should be specified. If this is not specified, PhysiPKPD will default to the concentration-based model. The two options are the concentration-based model and the amount-based model (see Table¬†<xref rid="gigabyte-2022-72-t004" ref-type="table">4</xref>). Both of these models use the area under the curve (AUC) of the internalized substrate to determine the current damage by the substrate on a cell. Future releases of PhysiPKPD may allow for SBML-defined damage accumulation functions. The experienced PhysiCell user can opt to use the already-implemented Intracellular features of PhysiCell to achieve this.</p>
        <table-wrap position="float" id="gigabyte-2022-72-t004">
          <label>Table¬†4</label>
          <caption>
            <p>Damage accumulation model specifications. The specification column indicates the string value to be used in the configuration file for the parameter S_on_C_pd_model.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col span="1" align="center" width="25%"/>
              <col span="1" align="center" width="55%"/>
              <col span="1" align="center" width="20%"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center" rowspan="1" colspan="1"> Model</th>
                <th align="center" rowspan="1" colspan="1"> Description</th>
                <th align="center" rowspan="1" colspan="1">Specification</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1"> Concentration-based</td>
                <td align="center" rowspan="1" colspan="1">Damage accumulates in a cell based on the concentration of the internalized substrate</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>AUC</monospace>
                </td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1"> Amount-based</td>
                <td align="center" rowspan="1" colspan="1"> Damage accumulates in a cell based on the amount of the internalized substrate</td>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>AUC_amount</monospace>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>For example, add the following to User Parameters in the configuration file: <monospace>&lt;S_on_C_pd_model type="string"&gt;AUC&lt;/S_on_C_pd_model&gt;</monospace>.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>For either model, let <italic toggle="yes">A</italic> represent the internalized substrate as either concentration or amount. Cells metabolize the substrate at a rate <italic toggle="yes">m</italic>. The damage accumulated by cells is proportional to the internalized substrate. This damage is repaired at the linear rate <italic toggle="yes">r</italic>
<sub>1</sub> and the constant rate <italic toggle="yes">r</italic>
<sub>0</sub>. As damage is an abstract quantity, the proportionality constant for the internalized substrate causing damage is set to 1. All three of these parameters (Table¬†<xref rid="gigabyte-2022-72-t005" ref-type="table">5</xref>) must be included in the custom data for <monospace>C</monospace>, the cell type affected by substrate <monospace>S</monospace>. The differential equations are then given by <disp-formula id="eqn0003"><label>(3)</label><alternatives><tex-math id="d2e1061">\documentclass[10pt]{article}
                    \usepackage{wasysym}
                    \usepackage[substack]{amsmath}
                    \usepackage{amsfonts}
                    \usepackage{amssymb}
                    \usepackage{amsbsy}
                    \usepackage[mathscr]{eucal}
                    \usepackage{mathrsfs}
                    \usepackage{pmc}
                    \usepackage[Euler]{upgreek}
                    \pagestyle{empty}
                    \oddsidemargin -1.0in \begin{document}
                    \begin{eqnarray}
                    {\displaystyle \frac{\text{d}A}{\text{d}t}=-mA}\\ {\displaystyle \frac{\text{d}D}{\text{d}t}=A-r_{1}D-r_{0}.}
                     \end{eqnarray}
                    \end{document}</tex-math><mml:math id="math003" display="block" overflow="scroll"><mml:mtable columnalign="right center left" rowspacing="3pt" columnspacing="0 thickmathspace" displaystyle="true"><mml:mtr><mml:mtd><mml:mtable columnalign="left" rowspacing="1.1em 0.4em" columnspacing="1em"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>‚àí</mml:mo><mml:mi>m</mml:mi><mml:mi>A</mml:mi></mml:mstyle></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mo>‚àí</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mi>D</mml:mi><mml:mo>‚àí</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula> This equation is solved by default at the mechanics time step. The user can change this by setting the parameter S_dt_C. PhysiPKPD uses the analytic solution to solve these dynamics. By default, PhysiPKPD does this by pre-computing the relevant quantities. However, in cases where the above parameters can vary by cell type, the user should set the parameter <monospace>PKPD_precompute_all_pd_quantities</monospace> to false. Finer-grained control can be set by S_precompute_pd_for_C, which overrides <monospace>PKPD_precompute_all_pd_quantities</monospace> on a case-by-case basis.</p>
        <table-wrap position="float" id="gigabyte-2022-72-t005">
          <label>Table¬†5</label>
          <caption>
            <p>Damage accumulation parameters.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col span="1" align="center" width="35%"/>
              <col span="1" align="center" width="45%"/>
              <col span="1" align="center" width="20%"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center" rowspan="1" colspan="1"> Parameter</th>
                <th align="center" rowspan="1" colspan="1"> Description</th>
                <th align="center" rowspan="1" colspan="1"> Units</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1"><monospace>S_metabolism_rate</monospace> (<italic toggle="yes">m</italic>)</td>
                <td align="center" rowspan="1" colspan="1">Metabolism rate of internalized substrate</td>
                <td align="center" rowspan="1" colspan="1">min<sup>‚àí1</sup>
</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1"><monospace>S_repair_rate_constant</monospace> (<italic toggle="yes">r</italic>
<sub>0</sub>)</td>
                <td align="center" rowspan="1" colspan="1"> Zero-order repair rate of damage</td>
                <td align="center" rowspan="1" colspan="1">damage/min</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1"><monospace>S_repair_rate_linear</monospace> (<italic toggle="yes">r</italic>
<sub>1</sub>)</td>
                <td align="center" rowspan="1" colspan="1"> First-order repair rate of damage</td>
                <td align="center" rowspan="1" colspan="1">min<sup>‚àí1</sup>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Set all in Custom Data of the cell definition of <monospace>C</monospace>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s0012">
        <title>Cell effect parameters</title>
        <p>To apply the desired MOA of <monospace>S</monospace> on <monospace>C</monospace>, the damage variable <monospace>S_damage</monospace> is used as the input to a Hill-type function. The user must specify three parameters for this Hill-type function in addition to identifying this MOA (see Table¬†<xref rid="gigabyte-2022-72-t006" ref-type="table">6</xref>). The four MOAs currently implemented in PhysiPKPD are proliferation (prolif), apoptosis (apop), necrosis (necrosis), and motility (motility). Replace X in Table¬†<xref rid="gigabyte-2022-72-t006" ref-type="table">6</xref> with the parenthetical name of the desired MOA. By default, all MOAs are assumed off, so including <monospace>S_moa_is_X</monospace> in the custom data is only necessary if set to true. Note that custom data in PhysiCell must be of type double, so ‚Äútrue‚Äù means a value &gt; 0.5.</p>
        <table-wrap position="float" id="gigabyte-2022-72-t006">
          <label>Table¬†6</label>
          <caption>
            <p>Cell effect parameters.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col span="1" align="center" width="20%"/>
              <col span="1" align="center" width="45%"/>
              <col span="1" align="center" width="35%"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center" rowspan="1" colspan="1"> Parameter</th>
                <th align="center" rowspan="1" colspan="1"> Description</th>
                <th align="center" rowspan="1" colspan="1"> Units</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_moa_is_X</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Identifies whether the MOA of <monospace>S</monospace> on <monospace>C</monospace> is X</td>
                <td align="center" rowspan="1" colspan="1">None (Values &gt; 0.5 trigger the MOA)</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_X_saturation_rate</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Limiting rate of X as damage from <monospace>S</monospace> grows towards¬†infinity</td>
                <td align="center" rowspan="1" colspan="1">min<sup>‚àí1</sup>
</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_X_EC50</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1">Damage from <monospace>S</monospace> at which the rate of X is halfway between the base and saturation rates</td>
                <td align="center" rowspan="1" colspan="1"> damage</td>
              </tr>
              <tr>
                <td align="center" rowspan="1" colspan="1">
                  <monospace>S_X_hill_power</monospace>
                </td>
                <td align="center" rowspan="1" colspan="1"> Hill power</td>
                <td align="center" rowspan="1" colspan="1"> None</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Replace X with one of the following: prolif, apop, necrosis, or motility.</p>
          </table-wrap-foot>
        </table-wrap>
        <sec id="s0013">
          <title>Multiply-targeted MOAs</title>
          <p>In the case that two or more substrates have the same MOA on a given cell type, we compute the drug effects as multipliers or factors. That is, the algorithm computes the saturation factor, <italic toggle="yes">f</italic>
<sub>sat</sub>, based on the user-supplied saturation rate and uses the damage to compute a factor, <italic toggle="yes">f</italic>, between 1 (no change) and the saturation factor (max change): <disp-formula id="eqn0004"><label>(4)</label><alternatives><tex-math id="d2e1315">\documentclass[10pt]{article}
                    \usepackage{wasysym}
                    \usepackage[substack]{amsmath}
                    \usepackage{amsfonts}
                    \usepackage{amssymb}
                    \usepackage{amsbsy}
                    \usepackage[mathscr]{eucal}
                    \usepackage{mathrsfs}
                    \usepackage{pmc}
                    \usepackage[Euler]{upgreek}
                    \pagestyle{empty}
                    \oddsidemargin -1.0in \begin{document}
                    \begin{eqnarray}
                    f=1+\frac{(f_{\text{sat}}-1)(D/EC50)^{n}}{1+(D/EC50)^{n}},f_{\text{sat}}=\frac{\text{saturation rate}}{\text{base rate}}. \end{eqnarray}
                    \end{document}</tex-math><mml:math id="math004" display="block" overflow="scroll"><mml:mtable columnalign="right center left" rowspacing="3pt" columnspacing="0 thickmathspace" displaystyle="true"><mml:mtr><mml:mtd><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mtext>sat</mml:mtext></mml:mrow></mml:msub><mml:mo>‚àí</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>E</mml:mi><mml:mi>C</mml:mi><mml:mn>50</mml:mn><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>E</mml:mi><mml:mi>C</mml:mi><mml:mn>50</mml:mn><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mtext>sat</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mtext>saturation rate</mml:mtext><mml:mtext>base rate</mml:mtext></mml:mfrac><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>When for¬†example, multiple substrates affect proliferation, the factors for each substrate are multiplied to give the final factor for the cell. In the case of necrosis, the base rate for necrosis is often set to 0, which causes problems in computing <italic toggle="yes">f</italic>
<sub>sat</sub>. Thus, we instead add the effects of multiple substrates targeting necrosis.</p>
          <fig position="float" id="gigabyte-2022-72-g003">
            <label>Figure 3.</label>
            <caption>
              <p>Results of the PhysiPKPD <monospace>pkpd-proliferation-sample</monospace>¬†example. An anti-proliferative drug enters the microenvironment from the bottom boundary (<italic toggle="yes">y</italic> = ‚àí400¬†Œºm) and diffuses up towards the tumor. (A) Snapshot of the simulation after 3 h. Drug concentration shown by contour plot. Cells colored by the current effect of drug damage on their proliferation rates. (B) Drug concentration in the microenvironment over time. The average is taken over the <italic toggle="yes">x</italic> dimension. (C) Average logarithm of cell damage over time. The average is taken over cells with positive damage only. The gray area represents +/‚àí the SD of the log-transformed damage. (D) IC50 curve generated from running this example with just one dose of the drug given at time <italic toggle="yes">t</italic> = 0 over 16 different dosesincluding a control with no drug. The mean and SD for each dose were computed from 5 samples. The tumor size at <italic toggle="yes">t</italic> = 48 h was relative to the control shown. Note: analysis and initial plotting of (A‚ÄìD) were done in MATLAB 2022a (RRID:<named-content content-type="rrid">SCR_001622</named-content>) using the output from the PhysiCell simulation. The code that produces these figures is not part of PhysiPKPD.</p>
            </caption>
            <graphic xlink:href="gigabyte-2022-72-g003" position="float"/>
          </fig>
        </sec>
        <sec id="s0014">
          <title>Resetting to base rates</title>
          <p>The implementation of PD is often done in the context of other dynamics. Typical examples used in the PhysiCell community include extracellular oxygen concentration and overcrowding (sometimes determined by simple pressure). PhysiPKPD therefore does not reset the MOA-targeted rates to their base value before applying the output of the Hill-type function. Thus, it is incumbent on the user to make sure the effects on these rates do not stack each time these effects are computed. See the <monospace>custom.cpp</monospace> files in any of the PhysiPKPD sample projects or the template projects to see how this can be done.</p>
        </sec>
      </sec>
    </sec>
    <sec id="s0015">
      <title>Example results</title>
      <p>We provide several examples of implementations of PhysiPKPD: one for each MOA, one combination therapy with one anti-proliferative drug and one pro-apoptotic drug (Figure¬†<xref rid="gigabyte-2022-72-g001" ref-type="fig">1</xref>A), and one using a confluence condition to start dosing. Follow the README.md file instructions to get PhysiPKPD set up in the root PhysiCell directory. The output will go to the output folder. There are many parameters that can be changed to explore various behaviors, even restricted to just one MOA. See Tables¬†<xref rid="gigabyte-2022-72-t002" ref-type="table">2</xref>,¬†<xref rid="gigabyte-2022-72-t003" ref-type="table">3</xref>,¬†<xref rid="gigabyte-2022-72-t005" ref-type="table">5</xref>, and¬†<xref rid="gigabyte-2022-72-t006" ref-type="table">6</xref> for the parameters and their descriptions unique to PhysiPKPD. In Figure <xref rid="gigabyte-2022-72-g003" ref-type="fig">3</xref>, we show the results from the anti-proliferative drug sample project, including creating an IC50 curve by varying the dose over several orders of magnitude.</p>
    </sec>
  </sec>
  <sec id="s0016">
    <title>Discussion</title>
    <p>A PKPD model that is ready to use ‚Äúout of the box‚Äù with PhysiCell will greatly benefit those seeking to use PhysiCell as a platform for agent-based modeling. It will also create a standard that can be used by any modeler looking to incorporate PKPD into their PhysiCell models.</p>
    <p>PhysiPKPD provides exactly this functionality. We designed PhysiPKPD so that the user can largely forego editing the C++ code, instead selecting PK/PD models and setting parameter values in the PhysiCell configuration file. By integrating with the native substrate class in PhysiCell, we can provide all these dynamics without introducing additional dependencies. When the PK models are the standard one- or two-compartment models, we use the analytic solution to provide fast and accurate updates to the pharmacokinetics. More importantly, the PD model also yields an analytic solution that we use to efficiently solve these dynamics, particularly compared to using numerical methods.</p>
    <p>The flexibility of PhysiPKPD allows the user to readily add as many drugs as desired and have them affect the various cell types in unique ways. Each drug can follow its own PK model, and if the one- and two-compartment models are not sufficient, an SBML-defined PK model can take their place. Each drug can affect each cell type in a unique way, combining any number of PhysiPKPD‚Äôs MOAs. By using the <monospace>damage_coloring</monospace> function of PhysiPKPD, a user can easily observe the extent to which up to two drugs are affecting a given cell type. This helps in narrowing down a parameter regime that results in observed and/or desired drug exposure and response.</p>
    <p>We have also aimed to make PhysiPKPD easy for others to pick up and use. The samples provided are a great place to start learning these capabilities of PhysiPKPD. For those looking to build a new project with PKPD included from the beginning, we provide two sample projects to help the user get started: one with and one without SBML support for a PK model. Finally, adding PK and/or PD to a substrate in a current PhysiCell project is simply a matter of adding the correct header files, updating the Makefile, and adding the parameters to the configuration file.</p>
    <p>There are many improvements and additions we hope to make to PhysiPKPD in the near future. With regards to PK, we hope to make it easier to include dosing events in an SBML file by allowing the user to supply a PK model and a CSV with the dosing information. With regards to PD, there are many features that can be added to allow for greater flexibility in terms of mechanisms of action, effect models, and integration with intracellular signaling. We have so far assumed that the AUC of a substrate inside a given cell, what we called damage, can be used to determine the effect of a drug on that cell. This is similar to irreversible effects models that use the AUC of the drug concentration to determine the response <styled-content style-type="bibr-wrapper">[<xref rid="ref16" ref-type="bibr">16</xref>]</styled-content>. Many other effects models have been used, including simple direct effect, indirect response, and signal transduction models¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref17" ref-type="bibr">17</xref>]</styled-content>. Recent work has used Bayesian inference to determine the distribution of delay times in response to therapeutic agents¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref18" ref-type="bibr">18</xref>]</styled-content>, making stochastic effects models an appealing next step as well. This could be added directly into previously-studied intracellular models or be used as a means to coarse-grain such complex models while still allowing for heterogeneity within cell types.</p>
    <p>We are also working with the makers of PhysiCell to further simplify and standardize the integration of PhysiPKPD into PhysiCell. A key goal of this partnership will be to allow the user to include PKPD while only needing to specify the relevant parameters and without directly interacting with the C++ code.</p>
    <p>We look forward to continuing to develop this tool as the community uses it and seeks new features.</p>
  </sec>
  <sec id="s0017">
    <title>Availability of source code and requirements</title>
    <p>
      <list list-type="bullet">
        <list-item>
          <p>Project name: ¬†PhysiPKPD</p>
        </list-item>
        <list-item>
          <p>Project home page: ¬†<ext-link xlink:href="https://github.com/drbergman/PhysiPKPD" ext-link-type="uri" specific-use="url">https://github.com/drbergman/PhysiPKPD</ext-link></p>
        </list-item>
        <list-item>
          <p>Operating system(s): ¬†Platform independent</p>
        </list-item>
        <list-item>
          <p>Programming language: ¬†C++</p>
        </list-item>
        <list-item>
          <p>Other requirements: ¬†PhysiCell 1.10.4 or higher, libRoadRunner</p>
        </list-item>
        <list-item>
          <p>License: e.g.¬†BSD 3-clause license</p>
        </list-item>
        <list-item>
          <p>RRID:<named-content content-type="rrid">SCR_022941</named-content></p>
        </list-item>
      </list>
    </p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgements</title>
    <p>We would like to thank the PhysiCell team for all the help they have provided along the way. In particular, we would like to thank Paul Macklin, Randy Heiland, John Metzcar and Furkan Kurtoglu.</p>
  </ack>
  <sec sec-type="data-availability" id="s0018">
    <title>Data Availability</title>
    <p>Snapshots of the code and underlying data is available from the GigaScience GigaDB repository¬†<styled-content style-type="bibr-wrapper">[<xref rid="ref19" ref-type="bibr">19</xref>]</styled-content>.</p>
  </sec>
  <sec id="s0019">
    <title>Declarations</title>
    <sec id="s0020">
      <title>List of abbreviations</title>
      <p>ABM: agent-based model; AUC: area under the curve; MOA: mechanism-of-action; PD: pharmacodynamics; PK: pharamcokinetics; SBML: Systems Biology Markup Language.</p>
    </sec>
    <sec id="s0021">
      <title>Ethical Approval</title>
      <p>Not applicable.</p>
    </sec>
    <sec sec-type="COI-statement" id="s0022">
      <title>Competing Interests</title>
      <p>TM is an employee of Bristol-Myers Squibb.</p>
    </sec>
    <sec id="s0023">
      <title>Funding</title>
      <p>None.</p>
    </sec>
    <sec id="s0024">
      <title>Author‚Äôs Contributions</title>
      <p>Conceptualization: DB, LM, MC, TM; Methodology: DB; Software: DB, LM, MC, DM, SB; Validation: DB, LM, MC, DM, SB, TM, JL; Visualization: DB; Writing ‚Äì original draft: DB; Writing ‚Äì review &amp; editing: DB, LM, MC, DM, SB, TM, JL.</p>
    </sec>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffarizadeh</surname><given-names>A</given-names></name>, <name><surname>Friedman</surname><given-names>SH</given-names></name>, <name><surname>Macklin</surname><given-names>P</given-names></name>. </person-group><article-title>BioFVM: an efficient, parallelized diffusive transport solver for 3-D biological simulations</article-title>. <source>Bioinformatics</source>, <year>2016</year>; <volume>32</volume>(<issue>8</issue>): <fpage>1256</fpage>‚Äì<lpage>1258</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1093/bioinformatics/btv730" ext-link-type="uri" specific-use="url">https://doi.org/10.1093/bioinformatics/btv730</ext-link></named-content>.<pub-id pub-id-type="pmid">26656933</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffarizadeh</surname><given-names>A</given-names></name>, <name><surname>Heiland</surname><given-names>R</given-names></name>, <name><surname>Friedman</surname><given-names>SH</given-names></name><etal/></person-group><article-title>PhysiCell: an open source physics-based cell simulator for 3-D multicellular systems</article-title>. <source>PLoS Comput. Biol.</source>, <year>2018</year>; <volume>14</volume>(<issue>2</issue>): <elocation-id content-type="artnum">e1005991</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1371/journal.pcbi.1005991" ext-link-type="uri" specific-use="url">https://doi.org/10.1371/journal.pcbi.1005991</ext-link></named-content>.<pub-id pub-id-type="pmid">29474446</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letort</surname><given-names>G</given-names></name>, <name><surname>Montagud</surname><given-names>A</given-names></name>, <name><surname>Stoll</surname><given-names>G</given-names></name><etal/></person-group><article-title>PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling</article-title>. <source>Bioinformatics</source>, <year>2019</year>; <volume>35</volume>(<issue>7</issue>): <fpage>1188</fpage>‚Äì<lpage>1196</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1093/bioinformatics/bty766" ext-link-type="uri" specific-use="url">https://doi.org/10.1093/bioinformatics/bty766</ext-link></named-content>.<pub-id pub-id-type="pmid">30169736</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Z</given-names></name>, <name><surname>Su</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model</article-title>. <source>Oncotarget</source>, <year>2017</year>; <volume>8</volume>(<issue>5</issue>): <fpage>7647</fpage>‚Äì<lpage>7665</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.18632/oncotarget.13831" ext-link-type="uri" specific-use="url">https://doi.org/10.18632/oncotarget.13831</ext-link></named-content>.<pub-id pub-id-type="pmid">28032590</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Tan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis</article-title>. <source>BMC Bioinform.</source>, <year>2012</year>; <volume>13</volume>(<issue>1</issue>): <elocation-id content-type="artnum">218</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1186/1471-2105-13-218" ext-link-type="uri" specific-use="url">https://doi.org/10.1186/1471-2105-13-218</ext-link></named-content>.</mixed-citation>
    </ref>
    <ref id="ref6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kather</surname><given-names>JN</given-names></name>, <name><surname>Poleszczuk</surname><given-names>J</given-names></name>, <name><surname>Suarez-Carmona</surname><given-names>M</given-names></name><etal/></person-group><article-title>In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer</article-title>. <source>Cancer Res.</source>, <year>2017</year>; <volume>77</volume>(<issue>22</issue>): <fpage>6442</fpage>‚Äì<lpage>6452</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1158/0008-5472.CAN-17-2006" ext-link-type="uri" specific-use="url">https://doi.org/10.1158/0008-5472.CAN-17-2006</ext-link></named-content>.<pub-id pub-id-type="pmid">28923860</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>C</given-names></name>, <name><surname>Milberg</surname><given-names>O</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition</article-title>. <source>J. R. Soc. Interface</source>, <year>2017</year>; <volume>14</volume>(<issue>134</issue>): <elocation-id content-type="artnum">20170320</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1098/rsif.2017.0320" ext-link-type="uri" specific-use="url">https://doi.org/10.1098/rsif.2017.0320</ext-link></named-content>.<pub-id pub-id-type="pmid">28931635</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenner</surname><given-names>AL</given-names></name>, <name><surname>Smalley</surname><given-names>M</given-names></name>, <name><surname>Goldman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy</article-title>. <source>iScience</source>, <year>2022</year>; <volume>25</volume>(<issue>6</issue>): <elocation-id content-type="artnum">104395</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1016/j.isci.2022.104395" ext-link-type="uri" specific-use="url">https://doi.org/10.1016/j.isci.2022.104395</ext-link></named-content>.<pub-id pub-id-type="pmid">35637733</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahbar</surname><given-names>S</given-names></name>, <name><surname>Shafiekhani</surname><given-names>S</given-names></name>, <name><surname>Allahverdi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Agent-based modeling of tumor and immune system interactions in combinational therapy with low-dose 5-fluorouracil and dendritic cell vaccine in Melanoma B16F10</article-title>. <source>Iranian J. Allergy Asthma Immunol.</source>, <year>2022</year>; <volume>21</volume>(<issue>2</issue>): <fpage>151</fpage>‚Äì<lpage>166</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.18502/ijaai.v21i2.9223" ext-link-type="uri" specific-use="url">https://doi.org/10.18502/ijaai.v21i2.9223</ext-link></named-content>.</mixed-citation>
    </ref>
    <ref id="ref10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzban</surname><given-names>S</given-names></name>, <name><surname>Han</surname><given-names>R</given-names></name>, <name><surname>Juh√°sz</surname><given-names>N</given-names></name><etal/></person-group><article-title>A hybrid PDE‚ÄìABM model for viral dynamics with application to SARS-CoV-2 and influenza</article-title>. <source>R. Soc. Open Sci.</source>, <year>2021</year>; <volume>8</volume>(<issue>11</issue>): <elocation-id content-type="artnum">210787</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1098/rsos.210787" ext-link-type="uri" specific-use="url">https://doi.org/10.1098/rsos.210787</ext-link></named-content>.<pub-id pub-id-type="pmid">34737874</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname><given-names>S</given-names></name>, <name><surname>DE</surname><given-names>Kirschner</given-names></name>. </person-group><article-title>A multi-compartment hybrid computational model predicts key roles for dendritic cells in tuberculosis infection</article-title>. <source>Computation</source>, <year>2016</year>; <volume>4</volume>(<issue>4</issue>): <elocation-id content-type="artnum">39</elocation-id>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.3390/computation4040039" ext-link-type="uri" specific-use="url">https://doi.org/10.3390/computation4040039</ext-link></named-content>.<pub-id pub-id-type="pmid">28989808</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <label>12</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pappalardo</surname><given-names>F</given-names></name>, <name><surname>Russo</surname><given-names>G</given-names></name>, <name><surname>Pennisi</surname><given-names>M</given-names></name><etal/></person-group><part-title>An agent based modeling approach for the analysis of tuberculosis‚Äìimmune system dynamics</part-title>. In: <source>2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)</source>. <publisher-name>IEEE</publisher-name>, <year>2018</year>; pp. <fpage>1386</fpage>‚Äì<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1109/BIBM.2018.8621355</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurber</surname><given-names>GM</given-names></name>, <name><surname>Schmidt</surname><given-names>MM</given-names></name>, <name><surname>Wittrup</surname><given-names>KD</given-names></name>. </person-group><article-title>Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance</article-title>. <source>Adv. Drug Deliv. Rev.</source>, <year>2008</year>; <volume>60</volume>(<issue>12</issue>): <fpage>1421</fpage>‚Äì<lpage>1434</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1016/j.addr.2008.04.012" ext-link-type="uri" specific-use="url">https://doi.org/10.1016/j.addr.2008.04.012</ext-link></named-content>.<pub-id pub-id-type="pmid">18541331</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoops</surname><given-names>S</given-names></name>, <name><surname>Sahle</surname><given-names>S</given-names></name>, <name><surname>Gauges</surname><given-names>R</given-names></name><etal/></person-group><article-title>COPASI‚Äîa complex pathway simulator</article-title>. <source>Bioinformatics</source>, <year>2006</year>; <volume>22</volume>(<issue>24</issue>): <fpage>3067</fpage>‚Äì<lpage>3074</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1093/bioinformatics/btl485" ext-link-type="uri" specific-use="url">https://doi.org/10.1093/bioinformatics/btl485</ext-link></named-content>.<pub-id pub-id-type="pmid">17032683</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <label>15</label>
      <mixed-citation publication-type="misc"><person-group person-group-type="author"><name><surname>K√∂nig</surname><given-names>M</given-names></name>. </person-group><article-title>sbmlutils: Python utilities for SBML</article-title>. Zenodo. <year>2022</year>; <pub-id pub-id-type="doi">10.5281/zenodo.6599299</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jusko</surname><given-names>WJ</given-names></name>. </person-group><article-title>Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents</article-title>. <source>J. Pharm. Sci.</source>, <year>1971</year>; <volume>60</volume>(<issue>6</issue>): <fpage>892</fpage>‚Äì<lpage>895</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1002/jps.2600600618" ext-link-type="uri" specific-use="url">https://doi.org/10.1002/jps.2600600618</ext-link></named-content>.<pub-id pub-id-type="pmid">5166939</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <label>17</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Felmlee</surname><given-names>MA</given-names></name>, <name><surname>Morris</surname><given-names>ME</given-names></name>, <name><surname>Mager</surname><given-names>DE</given-names></name>. </person-group><part-title>Mechanism-based pharmacodynamic modeling</part-title>. In: <source>Computational Toxicology</source>. <publisher-name>Springer</publisher-name>, <year>2012</year>; pp. <fpage>583</fpage>‚Äì<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-050-2_21</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>B</given-names></name>, <name><surname>Cheng</surname><given-names>YY</given-names></name>, <name><surname>Cinar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bayesian inference of distributed time delay in transcriptional and translational regulation</article-title>. <source>Bioinformatics</source>, <year>2020</year>; <volume>36</volume>(<issue>2</issue>): <fpage>586</fpage>‚Äì<lpage>593</lpage>.<named-content content-type="ext-link"><ext-link xlink:href="https://doi.org/10.1093/bioinformatics/btz574" ext-link-type="uri" specific-use="url">https://doi.org/10.1093/bioinformatics/btz574</ext-link></named-content>.<pub-id pub-id-type="pmid">31347688</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergman</surname><given-names>DR</given-names></name>, <name><surname>Marazzi</surname><given-names>L</given-names></name>, <name><surname>Chowkwale</surname><given-names>M</given-names></name><etal/></person-group><article-title>Supporting data for ‚ÄúPhysiPKPD: A pharmacokinetics and pharmacodynamics module for PhysiCell‚Äù</article-title>. <source>GigaScience Database</source>, <year>2022</year>; <pub-id pub-id-type="doi">10.5524/102338</pub-id>.</mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article article-type="author-comment" id="d1e1832">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Article Submission</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bergman</surname>
            <given-names>Daniel</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Author</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>13</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>15</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1838">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Assign Handling Editor</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Edmunds</surname>
            <given-names>Scott</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Editor in Chief</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1844">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Editor Assess MS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zhang</surname>
            <given-names>Hongfang</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Handling Editor</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1850">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Curator Assess MS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Hunter</surname>
            <given-names>Christopher</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Curator</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>16</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="reviewer-report" id="d1e1856">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Review MS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>West</surname>
            <given-names>Jeffrey</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Reviewer 1</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>29</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <p>
      <array>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Reviewer name and names of any other individual's who aided in reviewer</td>
            <td rowspan="1" colspan="1">Jeffrey West</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Do you understand and agree to our policy of having open and named reviews, and having your review included with the published manuscript. (If no, please inform the editor that you cannot review this manuscript.)</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the language of sufficient quality?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Please add additional comments on language quality to clarify if needed</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there a clear statement of need explaining what problems the software is designed to solve and who the target audience is? </td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the source code available, and has an appropriate Open Source Initiative license &lt;a href="https://opensource.org/licenses" target="_blank"&gt;(https://opensource.org/licenses)&lt;/a&gt; been assigned to the code?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">As Open Source Software are there guidelines on how to contribute, report issues or seek support on the code?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the code executable?</td>
            <td rowspan="1" colspan="1">Unable to test</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is installation/deployment sufficiently outlined in the paper and documentation, and does it proceed as outlined?</td>
            <td rowspan="1" colspan="1">Unable to test</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the documentation provided clear and user friendly?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there enough clear information in the documentation to install, run and test this tool, including information on where to seek help if required?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there a clearly-stated list of dependencies, and is the core functionality of the software documented to a satisfactory level?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Have any claims of performance been sufficiently tested and compared to other commonly-used packages? </td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is test data available, either included with the submission or openly available via cited third party sources (e.g. accession numbers, data DOIs)?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Are there (ideally real world) examples demonstrating use of the software? </td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is automated testing used or are there manual steps described so that the functionality of the software can be verified?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Any Additional Overall Comments to the Author</td>
            <td rowspan="1" colspan="1">This is a very nice &amp; useful extension to PhysiCell, in order to model PK/PD dynamics in agent-based simulations. Overall, the description of the software is good and easy to follow, but I offer a few suggestions for clarity:&#13; &#13; 1. In "Statement of Need" -- the phrase "how much gets to the cells and what they then do to the cells" is vague and casual -- maybe use standard terms like drug exposure &amp; response to describe PK/PD relationships&#13; 2. Final sentence in "Statement of Need" that says "Substrates can target any cell type with PD dynamics" -- can you elaborate? Does this indicate that every cell type can have unique PD dynamics?&#13; 3. In "Implementation" authors refer to Figure 2A and 2B but figure 2 only has one panel -- perhaps this should be figure 1A/B?&#13; 4. In "Pharmacodynamics" -- "the list of PK substrates and the list of PDsubstrates need not have any relationship" -- this is slightly confusing. I assume that every substrate can have associated PK dynamics without having an PD dynamic, but is the opposite true? If so, how what is the drug dispersal / decay rate?&#13; 5. Finally, the discussion section is focused mainly on future steps. I think it would be helpful for the discussion to focus more on current advantages and functionality. This is the publication record for this software, and as is often the case, future steps may be subject to change.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Recommendation</td>
            <td rowspan="1" colspan="1">Minor Revisions</td>
          </tr>
        </tbody>
      </array>
    </p>
  </body>
</sub-article>
<sub-article article-type="reviewer-report" id="d1e1862">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Review MS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Aguilar</surname>
            <given-names>Boris</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Reviewer 2</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>23</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>11</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <p>
      <array>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Reviewer name and names of any other individual's who aided in reviewer</td>
            <td rowspan="1" colspan="1">Boris Aguilar</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Do you understand and agree to our policy of having open and named reviews, and having your review included with the published manuscript. (If no, please inform the editor that you cannot review this manuscript.)</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the language of sufficient quality?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Please add additional comments on language quality to clarify if needed</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there a clear statement of need explaining what problems the software is designed to solve and who the target audience is? </td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the source code available, and has an appropriate Open Source Initiative license &lt;a href="https://opensource.org/licenses" target="_blank"&gt;(https://opensource.org/licenses)&lt;/a&gt; been assigned to the code?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">As Open Source Software are there guidelines on how to contribute, report issues or seek support on the code?</td>
            <td rowspan="1" colspan="1">No</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the code executable?</td>
            <td rowspan="1" colspan="1">No</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1">This code can not be in an. executable form as is an extension to PhysiCell</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is installation/deployment sufficiently outlined in the paper and documentation, and does it proceed as outlined?</td>
            <td rowspan="1" colspan="1">Unable to test</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1">I ma not familiar with running PhysiCell</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is the documentation provided clear and user friendly?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there enough clear information in the documentation to install, run and test this tool, including information on where to seek help if required?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is there a clearly-stated list of dependencies, and is the core functionality of the software documented to a satisfactory level?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Have any claims of performance been sufficiently tested and compared to other commonly-used packages? </td>
            <td rowspan="1" colspan="1">No</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1">Author claim this is the first time PKPD module has been added to PhysiCell. </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is test data available, either included with the submission or openly available via cited third party sources (e.g. accession numbers, data DOIs)?</td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Are there (ideally real world) examples demonstrating use of the software? </td>
            <td rowspan="1" colspan="1">Yes</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Is automated testing used or are there manual steps described so that the functionality of the software can be verified?</td>
            <td rowspan="1" colspan="1">No</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Additional Comments</td>
            <td rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Any Additional Overall Comments to the Author</td>
            <td rowspan="1" colspan="1">- I think there is mistake in calling Figure 1 in Installation sections, should be Figure 1.&#13; - Reference to PhysiBoSS missing &#13; - Figure 1 </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Recommendation</td>
            <td rowspan="1" colspan="1">Minor Revisions</td>
          </tr>
        </tbody>
      </array>
    </p>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="d1e1869">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Editor Decision</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zhang</surname>
            <given-names>Hongfang</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Handling Editor</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>11</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>11</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="author-comment" id="d1e1573">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Minor Revision</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bergman</surname>
            <given-names>Daniel</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Author</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>22</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>22</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1579">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Assess Revision</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zhang</surname>
            <given-names>Hongfang</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Handling Editor</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>22</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>31</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1585">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Final Data Preparation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Fan</surname>
            <given-names>Yannan</given-names>
            <prefix>Ms</prefix>
          </name>
          <role>Curator</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>04</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1591">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Editor Decision</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Zhang</surname>
            <given-names>Hongfang</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Handling Editor</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
<sub-article article-type="editor-report" id="d1e1597">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Accept</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Edmunds</surname>
            <given-names>Scott</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Editor in Chief</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <p>
      <array>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Comments to the Author</td>
            <td rowspan="1" colspan="1">Please finalize the GigaDB entry with the curators and we'll complete the proofing and switch the paper live.</td>
          </tr>
        </tbody>
      </array>
    </p>
  </body>
</sub-article>
<sub-article article-type="editor-report" id="d1e1603">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">GigaByte</journal-id>
      <journal-id journal-id-type="iso-abbrev">GigaByte</journal-id>
      <journal-id journal-id-type="publisher-id">Gigabyte</journal-id>
      <journal-title-group>
        <journal-title>GigaByte</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2709-4715</issn>
      <publisher>
        <publisher-name>Gigascience Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Export to Production</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Edmunds</surname>
            <given-names>Scott</given-names>
            <prefix>Dr</prefix>
          </name>
          <role>Editor in Chief</role>
        </contrib>
      </contrib-group>
      <history>
        <date date-type="event_start_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="event_complete_date">
          <day>10</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
    </article-meta>
  </front>
</sub-article>
